In Washington, there's an air of anticipation as the Trump Administration starts to take shape. Consumer issues didn't get ...

After Wednesday's rate decision, investors will watch the Friday morning release of November PCE data, which will help inform future Fed policy.

The U.S. Food and Drug Administration has declined to approve an injectable version of Johnson & Johnson's drug Rybrevant for ...

As 2024 comes to an end, investors are bracing for what the new year holds when it comes to the Federal Reserve and the ...

The head of Japan's SoftBank is set to announce plans on Monday to invest $100 billion in the United States over the next ...

Not long ago, the Fed's favorite measure of inflation looked tantalizingly close to the central bank's goal of a 2% annual ...

U.S. manufacturers are optimistic that the sector will emerge from a prolonged recession next year, though capital ...

It's becoming an essential part of credit card use and management, and not just because of the potential for bonus rewards ...

To be sure, the central bank has emphasized that it will adjust its rate decisions based on incoming economic data. Evidence ...

Dow Jones Industrial Average futures increased 47 points, or 0.11%, to 44,381 ...

The S&P 500 and Nasdaq are higher Monday as the stock market braces itself for the Fed's rate decision this week.

The Federal Reserve will announce a rate decision on Wednesday, Dec. 18. Economists are now expecting fewer cuts in 2025.